Today's Stocks Driving Success For The Health Services Industry

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 161 points (1.1%) at 14,992 as of Friday, May 3, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 2,292 issues advancing vs. 653 declining with 100 unchanged.

The Health Services industry currently sits up 0.9% versus the S&P 500, which is up 1.2%. Top gainers within the industry include Mettler-Toledo International ( MTD), up 8.0%, Tenet Healthcare ( THC), up 2.7%, Varian Medical Systems ( VAR), up 2.3%, CareFusion ( CFN), up 2.2% and Boston Scientific ( BSX), up 1.5%. On the negative front, top decliners within the industry include Select Medical Holdings Corporation ( SEM), down 7.13, Edwards Life ( EW), down 1.09 and Humana ( HUM), down 1.12.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry higher today:

5. Agilent Technologies ( A) is one of the companies pushing the Health Services industry higher today. As of noon trading, Agilent Technologies is up $0.44 (1.07) to $41.92 on average volume Thus far, 2.2 million shares of Agilent Technologies exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $41.90-$42.55 after having opened the day at $41.93 as compared to the previous trading day's close of $41.48.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $14.3 billion and is part of the health care sector. The company has a P/E ratio of 13.2, below the S&P 500 P/E ratio of 17.7. Shares are up 0.9% year to date as of the close of trading on Thursday. Currently there are 14 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agilent Technologies Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

4. As of noon trading, Medtronic ( MDT) is up $0.32 (0.67) to $47.76 on average volume Thus far, 1.9 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.3 million shares. The stock has ranged in price between $47.53-$47.96 after having opened the day at $47.59 as compared to the previous trading day's close of $47.44.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $47.3 billion and is part of the health care sector. The company has a P/E ratio of 14.2, below the S&P 500 P/E ratio of 17.7. Shares are up 15.7% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate Medtronic a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, increase in net income and attractive valuation levels. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Medtronic Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

3. As of noon trading, Thermo Fisher Scientific ( TMO) is up $0.59 (0.72) to $82.19 on light volume Thus far, 733,693 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $82.06-$82.59 after having opened the day at $82.10 as compared to the previous trading day's close of $81.60.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $29.0 billion and is part of the health care sector. The company has a P/E ratio of 22.1, above the S&P 500 P/E ratio of 17.7. Shares are up 27.9% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Thermo Fisher Scientific Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

2. As of noon trading, Intuitive Surgical ( ISRG) is up $8.04 (1.63) to $499.90 on light volume Thus far, 128,221 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 498,500 shares. The stock has ranged in price between $495.35-$500.42 after having opened the day at $497.44 as compared to the previous trading day's close of $491.86.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $19.7 billion and is part of the health care sector. The company has a P/E ratio of 28.8, above the S&P 500 P/E ratio of 17.7. Shares are down 0.0% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Intuitive Surgical a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

1. As of noon trading, Express Scripts ( ESRX) is up $0.63 (1.04) to $61.63 on average volume Thus far, 3.3 million shares of Express Scripts exchanged hands as compared to its average daily volume of 5.8 million shares. The stock has ranged in price between $61.12-$61.92 after having opened the day at $61.21 as compared to the previous trading day's close of $61.00.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $48.7 billion and is part of the health care sector. The company has a P/E ratio of 35.3, above the S&P 500 P/E ratio of 17.7. Shares are up 10.4% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, good cash flow from operations, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Express Scripts Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers